JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2011, 60(4):182-188

Prosolv® Easytab as a new multifunctional co-processed dry binder: a study of the properties of tablets and energy evaluation of the compaction process

Jitka Mužíková*, Pavlína Mašatová
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Technology, Czech Republic

The paper studies the tensile strength and disintegration time of tablets made from the new co-processed dry binder Prosolv® Easytab. The results are compared with Prosolv® SMCC 90 and the physical mixtures of Prosolv SMCC 90 with Explotab (1% or 1.5%) and Pruv (0.5% or 1%). It also evaluates the mixtures with the active ingredients ascorbic acid and acetylsalicylic acid. The process of compaction of the new excipient is studied also from the energetic aspect. The tablets made from the substance Prosolv Easytab possessed a lower strength than those from Prosolv SMCC 90 and the physical mixtures of Prosolv SMCC 90 with Explotab and Pruv. The disintegration time of tablets was markedly shorter in the case of the substance Prosolv Easytab than in Prosolv SMCC 90, the shortest being in the tablets made from the physical mixtures of substances. From the energetic aspect, Prosolv Easytab was the best compressible one, because under the given compression force the value of the maximal energy was the lowest one of the all tableting compositions under study, primarily due to a lower energy for friction and the energy accumulated by the tablet.

Keywords: Prosolv Easytab; Prosolv SMCC 90; tensile strength of tablets; disintegration time; force-displacement profile
Grants and funding:

The study was supported by the grant MSM 0021620822 and by the firm JRS PHARMA, which supplied the samples of the dry binders tested.

Received: May 26, 2011; Accepted: June 9, 2011; Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mužíková J, Mašatová P. Prosolv® Easytab as a new multifunctional co-processed dry binder: a study of the properties of tablets and energy evaluation of the compaction process. Čes. slov. farm. 2011;60(4):182-188.
Download citation

References

  1. Carlin, B. A. C.: Direct compression and the role of filler- binders. In: Augsburger, L. L., Hoag S. W. eds. Pharmaceutical dosage forms: Tablets, Vol. 2, 3th ed. New York: Informa Healthcare USA, Inc. 2008; 173-216.
  2. Allen, J. D.: Improving DC with SMCC. Manuf. Chemist. 1996; 67, 19-23. Go to original source...
  3. Sherwood, B. E., Becker, J.W.: A new class of high - functionality excipients : Silicified microcrystalline cellulose. Pharm. Tech. 1998; 22, 78-88.
  4. Tobyn, M. J., McCarthy, G. P., Staniforth, J. N., Edge, S.: Physicochemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose. Int. J. Pharm. 1998; 169: 183-194. Go to original source...
  5. Edge, S., Steele, F., Chen, A., Tobyn, M., Staniforth, J. N.: The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose. Int. J. Pharm. 2000; 200: 67-72. Go to original source... Go to PubMed...
  6. Hwang, R., Peck, G. R.: Compression and tablet characteristics of various types of microcrystalline cellulose. Pharm. Technol. 2001; 25, 1-11.
  7. Van Veen, B., Bolhuis, G. K., Wu, Y. S., Zuurman, K., Frijlink, H. W.: Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose. Eur. J. Pharm. Biopharm. 2005; 59, 133-138. Go to original source... Go to PubMed...
  8. Steele, D. F., Tobyn, M., Edge, S., Chen, A., Staniforth, J. N.: Physicomechanical and mechanical evaluation of a novel high density grade of silicified microcrystalline cellulose. Drug Dev. Ind. Pharm. 2004; 30, 103-109. Go to original source... Go to PubMed...
  9. Mužíková, J., Nováková, P.: A study of the properties of compacts from silicified microcrystalline celluloses. Drug Dev. Ind. Pharm. 2007; 33, 775-781. Go to original source... Go to PubMed...
  10. JRS Pharma (2010). Prosolv® Easytab. Fir. Lit. http://www.jrspharma.de/Pharma/wEnglisch/produktinfo/productinfo_prosolv_easytab.shtml
  11. Ragnarsson, G.: Force-displacement and network measurements. In Alderborn, G., Nystrőm, Ch. eds. Pharmaceutical Powder Compaction Technology New York: Marcel Dekker, Inc. 1996; 77-97. Go to original source...
  12. Fell, J. T., Newton, J. M.: Determination of tablet strength by diametral-compression test. J. Pharm. Sci. 1970; 59, 688-691. Go to original source... Go to PubMed...
  13. Belousov, V. A.: K voprosu o vybore optimalnikh davlenii pressovania pri tabletirovanii lekarstvennykh poroshkov. Khim. Farm. Zh. 1976; 10, 105-111.
  14. Bolhuis, G. K., Chowhan, Z. T.: Materials for direct compaction. In: G. Alderborn, G., Nystrőm, Ch. eds. Pharmaceutical Powder Compaction Technology. New York: Marcel Dekker, Inc. 1996; 419-500. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.